{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:55:20Z","timestamp":1790380520223,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["1U01CA215547"],"award-info":[{"award-number":["1U01CA215547"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Utilization of RNA sequencing methods to measure gene expression from archival formalin-fixed paraffin-embedded (FFPE) tumor samples in translational research and clinical trials requires reliable interpretation of the impact of pre-analytical variables on the data obtained, particularly the methods used to preserve samples and to purify RNA.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Matched tissue samples from 12 breast cancers were fresh frozen (FF) and preserved in RNA<jats:italic>later<\/jats:italic> or fixed in formalin and processed as FFPE tissue. Total RNA was extracted and purified from FF samples using the Qiagen RNeasy kit, and in duplicate from FFPE tissue sections using three different kits (Norgen, Qiagen and Roche). All RNA samples underwent whole transcriptome RNA sequencing (wtRNAseq) and targeted RNA sequencing for 31 transcripts included in a signature of sensitivity to endocrine therapy. We assessed the effect of RNA extraction kit on the reliability of gene expression levels using linear mixed-effects model analysis, concordance correlation coefficient (CCC) and differential analysis. All protein-coding genes in the wtRNAseq and three gene expression signatures for breast cancer were assessed for concordance.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Despite variable quality of the RNA extracted from FFPE samples by different kits, all had similar concordance of overall gene expression from wtRNAseq between matched FF and FFPE samples (median CCC 0.63\u20130.66) and between technical replicates (median expression difference 0.13\u20130.22). More than half of genes were differentially expressed between FF and FFPE, but with low fold change (median |LFC| 0.31\u20130.34). Two out of three breast cancer signatures studied were highly robust in all samples using any kit, whereas the third signature was similarly discordant irrespective of the kit used. The targeted RNAseq assay was concordant between FFPE and FF samples using any of the kits (CCC 0.91\u20130.96).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The selection of kit to purify RNA from FFPE did not influence the overall quality of results from wtRNAseq, thus variable reproducibility of gene signatures probably relates to the reliability of individual gene selected and possibly to the algorithm. Targeted RNAseq showed promising performance for clinical deployment of quantitative assays in breast cancer from FFPE samples, although numerical scores were not identical to those from wtRNAseq and would require calibration.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-019-6363-0","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T17:17:04Z","timestamp":1575566224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues"],"prefix":"10.1186","volume":"19","author":[{"given":"Michal","family":"Marczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Trevarton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno V.","family":"Sinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah E.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajos","family":"Pusztai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Hatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1526-184X","authenticated-orcid":false,"given":"W. Fraser","family":"Symmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"key":"6363_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ymeth.2017.06.032","volume":"131","author":"S Lal","year":"2017","unstructured":"Lal S, McCart Reed AE, de Luca XM, Simpson PT. Molecular signatures in breast cancer. Methods. 2017;131:135\u201346.","journal-title":"Methods"},{"issue":"5","key":"6363_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrg.2016.10","volume":"17","author":"SA Byron","year":"2016","unstructured":"Byron SA, Van Keuren-Jensen KR, Engelthaler DM, Carpten JD, Craig DW. Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nat Rev Genet. 2016;17(5):257\u201371.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"6363_CR3","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1186\/1471-2164-15-1008","volume":"15","author":"D Fumagalli","year":"2014","unstructured":"Fumagalli D, Blanchet-Cohen A, Brown D, Desmedt C, Gacquer D, Michiels S, Roth\u00e9 F, Majjaj S, Salgado R, Larsimont D, et al. Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-sequencing technology. BMC Genomics. 2014;15(1):1008.","journal-title":"BMC Genomics"},{"key":"6363_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nmeth.2483","volume":"10","author":"X Adiconis","year":"2013","unstructured":"Adiconis X, Borges-Rivera D, Satija R, DeLuca DS, Busby MA, Berlin AM, Sivachenko A, Thompson DA, Wysoker A, Fennell T, et al. Comparative analysis of RNA sequencing methods for degraded or low-input samples. Nat Methods. 2013;10:623.","journal-title":"Nat Methods"},{"key":"6363_CR5","doi-asserted-by":"publisher","first-page":"12335","DOI":"10.1038\/srep12335","volume":"5","author":"S Graw","year":"2015","unstructured":"Graw S, Meier R, Minn K, Bloomer C, Godwin AK, Fridley B, Vlad A, Beyerlein P, Chien J. Robust gene expression and mutation analyses of RNA-sequencing of formalin-fixed diagnostic tumor samples. Sci Rep. 2015;5:12335.","journal-title":"Sci Rep"},{"issue":"5","key":"6363_CR6","doi-asserted-by":"publisher","first-page":"e98187","DOI":"10.1371\/journal.pone.0098187","volume":"9","author":"J Hedegaard","year":"2014","unstructured":"Hedegaard J, Thorsen K, Lund MK, Hein AM, Hamilton-Dutoit SJ, Vang S, Nordentoft I, Birkenkamp-Demtroder K, Kruhoffer M, Hager H, et al. Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue. PLoS One. 2014;9(5):e98187.","journal-title":"PLoS One"},{"issue":"11","key":"6363_CR7","doi-asserted-by":"publisher","first-page":"e81925","DOI":"10.1371\/journal.pone.0081925","volume":"8","author":"N Norton","year":"2013","unstructured":"Norton N, Sun Z, Asmann YW, Serie DJ, Necela BM, Bhagwate A, Jen J, Eckloff BW, Kalari KR, Thompson KJ, et al. Gene expression, single nucleotide variant and fusion transcript discovery in archival material from breast tumors. PLoS One. 2013;8(11):e81925.","journal-title":"PLoS One"},{"issue":"4","key":"6363_CR8","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.18632\/oncotarget.14257","volume":"8","author":"R Chen","year":"2017","unstructured":"Chen R, Guan Q, Cheng J, He J, Liu H, Cai H, Hong G, Zhang J, Li N, Ao L, et al. Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples. Oncotarget. 2017;8(4):6652\u201362.","journal-title":"Oncotarget"},{"issue":"1","key":"6363_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1741-7007-12-42","volume":"12","author":"I Gallego Romero","year":"2014","unstructured":"Gallego Romero I, Pai AA, Tung J, Gilad Y. RNA-seq: impact of RNA degradation on transcript quantification. BMC Biol. 2014;12(1):42.","journal-title":"BMC Biol"},{"issue":"1","key":"6363_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12864-017-3827-y","volume":"18","author":"S Schuierer","year":"2017","unstructured":"Schuierer S, Carbone W, Knehr J, Petitjean V, Fernandez A, Sultan M, Roma G. A comprehensive assessment of RNA-seq protocols for degraded and low-quantity samples. BMC Genomics. 2017;18(1):442.","journal-title":"BMC Genomics"},{"issue":"1","key":"6363_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12864-018-4761-3","volume":"19","author":"N Bossel Ben-Moshe","year":"2018","unstructured":"Bossel Ben-Moshe N, Gilad S, Perry G, Benjamin S, Balint-Lahat N, Pavlovsky A, Halperin S, Markus B, Yosepovich A, Barshack I, et al. mRNA-seq whole transcriptome profiling of fresh frozen versus archived fixed tissues. BMC Genomics. 2018;19(1):419.","journal-title":"BMC Genomics"},{"key":"6363_CR12","doi-asserted-by":"publisher","unstructured":"Li J, Fu C, Speed TP, Wang W, Symmans WF. Accurate RNA sequencing from formalin-fixed cancer tissue to represent high-quality transcriptome from frozen tissue. JCO Precis Oncol. 2018;2018. https:\/\/doi.org\/10.1200\/PO.17.00091.","DOI":"10.1200\/PO.17.00091"},{"issue":"1","key":"6363_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41523-019-0111-0","volume":"5","author":"BV Sinn","year":"2019","unstructured":"Sinn BV, Fu C, Lau R, Litton J, Tsai T-H, Murthy R, Tam A, Andreopoulou E, Gong Y, Murthy R, et al. SETER\/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer. NPJ Breast Cancer. 2019;5(1):16.","journal-title":"NPJ Breast Cancer"},{"issue":"24","key":"6363_CR14","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/jnci\/djr438","volume":"103","author":"C Hatzis","year":"2011","unstructured":"Hatzis C, Sun H, Yao H, Hubbard RE, Meric-Bernstam F, Babiera GV, Wu Y, Pusztai L, Symmans WF. Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers. J Natl Cancer I. 2011;103(24):1871\u201383.","journal-title":"J Natl Cancer I"},{"issue":"6","key":"6363_CR15","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/nar\/gni054","volume":"33","author":"S Imbeaud","year":"2005","unstructured":"Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E, Mueller O, Schroeder A, Auffray C. Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res. 2005;33(6):e56.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6363_CR16","doi-asserted-by":"publisher","first-page":"6351","DOI":"10.1038\/s41598-018-24781-6","volume":"8","author":"I Wimmer","year":"2018","unstructured":"Wimmer I, Tr\u00f6scher AR, Brunner F, Rubino SJ, Bien CG, Weiner HL, Lassmann H, Bauer J. Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh, fresh frozen and formalin-fixed paraffin-embedded tissue samples. Sci Rep. 2018;8(1):6351.","journal-title":"Sci Rep"},{"key":"6363_CR17","volume-title":"FastQC: a quality control tool for high throughput sequence data","author":"S Andrews","year":"2014","unstructured":"Andrews S. FastQC: a quality control tool for high throughput sequence data; 2014."},{"issue":"15","key":"6363_CR18","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320.","journal-title":"Bioinformatics"},{"issue":"1","key":"6363_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"16","key":"6363_CR20","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","volume":"28","author":"L Wang","year":"2012","unstructured":"Wang L, Wang S, Li W. RSeQC: quality control of RNA-seq experiments. Bioinformatics. 2012;28(16):2184\u20135.","journal-title":"Bioinformatics"},{"issue":"1","key":"6363_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12859-016-0922-z","volume":"17","author":"L Wang","year":"2016","unstructured":"Wang L, Nie J, Sicotte H, Li Y, Eckel-Passow JE, Dasari S, Vedell PT, Barman P, Wang L, Weinshiboum R, et al. Measure transcript integrity using RNA-seq data. BMC Bioinformatics. 2016;17(1):58.","journal-title":"BMC Bioinformatics"},{"key":"6363_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.","journal-title":"BMC Bioinformatics"},{"issue":"18","key":"6363_CR23","doi-asserted-by":"publisher","first-page":"6012","DOI":"10.1158\/1078-0432.CCR-11-0926","volume":"17","author":"M Filipits","year":"2011","unstructured":"Filipits M, Rudas M, Jakesz R, Dubsky P, Fitzal F, Singer CF, Dietze O, Greil R, Jelen A, Sevelda P, et al. A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. Clin Cancer Res. 2011;17(18):6012\u201320.","journal-title":"Clin Cancer Res"},{"issue":"27","key":"6363_CR24","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27):2817\u201326.","journal-title":"N Engl J Med"},{"issue":"7","key":"6363_CR25","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/bioinformatics\/btv693","volume":"32","author":"DM Gendoo","year":"2016","unstructured":"Gendoo DM, Ratanasirigulchai N, Schroder MS, Pare L, Parker JS, Prat A, Haibe-Kains B. Genefu: an R\/Bioconductor package for computation of gene expression-based signatures in breast cancer. Bioinformatics. 2016;32(7):1097\u20139.","journal-title":"Bioinformatics"},{"issue":"27","key":"6363_CR26","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1200\/JCO.2010.28.4273","volume":"28","author":"WF Symmans","year":"2010","unstructured":"Symmans WF, Hatzis C, Sotiriou C, Andre F, Peintinger F, Regitnig P, Daxenbichler G, Desmedt C, Domont J, Marth C, et al. Genomic index of sensitivity to endocrine therapy for breast cancer. J Clin Oncol. 2010;28(27):4111\u20139.","journal-title":"J Clin Oncol"},{"key":"6363_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2307\/2532051","volume":"45","author":"L Lin","year":"1989","unstructured":"Lin L. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45:255\u201368.","journal-title":"Biometrics"},{"issue":"7","key":"6363_CR28","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6363_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):48.","journal-title":"J Stat Softw"},{"issue":"12","key":"6363_CR30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"key":"6363_CR31","doi-asserted-by":"publisher","first-page":"25533","DOI":"10.1038\/srep25533","volume":"6","author":"S Parekh","year":"2016","unstructured":"Parekh S, Ziegenhain C, Vieth B, Enard W, Hellmann I. The impact of amplification on differential expression analyses by RNA-seq. Sci Rep. 2016;6:25533.","journal-title":"Sci Rep"},{"issue":"1","key":"6363_CR32","doi-asserted-by":"publisher","first-page":"e0170632","DOI":"10.1371\/journal.pone.0170632","volume":"12","author":"A Esteve-Codina","year":"2017","unstructured":"Esteve-Codina A, Arpi O, Martinez-Garc\u00eda M, Pineda E, Mallo M, Gut M, Carrato C, Rovira A, Lopez R, Tortosa A, et al. A comparison of RNA-Seq results from paired formalin-fixed paraffin-embedded and fresh-frozen glioblastoma tissue samples. PLoS One. 2017;12(1):e0170632.","journal-title":"PLoS One"},{"key":"6363_CR33","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nbt.2957","volume":"32","author":"SM-I Consortium","year":"2014","unstructured":"Consortium SM-I, Su Z, \u0141abaj PP, Li S, Thierry-Mieg J, Thierry-Mieg D, Shi W, Wang C, Schroth GP, Setterquist RA, et al. A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the sequencing quality control Consortium. Nat Biotechnol. 2014;32:903.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"6363_CR34","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nbt.2972","volume":"32","author":"S Li","year":"2014","unstructured":"Li S, Tighe SW, Nicolet CM, Grove D, Levy S, Farmerie W, Viale A, Wright C, Schweitzer PA, Gao Y, et al. Multi-platform assessment of transcriptome profiling using RNA-seq in the ABRF next-generation sequencing study. Nat Biotechnol. 2014;32(9):915\u201325.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"6363_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4048\/jbc.2017.20.4.393","volume":"20","author":"Y Choi","year":"2017","unstructured":"Choi Y, Kim A, Kim J, Lee J, Lee SY, Kim C. Optimization of RNA extraction from formalin-fixed paraffin-embedded blocks for targeted next-generation sequencing. J Breast Cancer. 2017;20(4):393\u20139.","journal-title":"J Breast Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6363-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6363-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6363-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:08:26Z","timestamp":1607040506000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6363-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6363"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6363-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"19 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involved human subjects research and was carried out in compliance with the Helsinki Declaration with review and oversight from the Institutional Review Board of MD Anderson Cancer Center (protocol LAB08\u20130824). The need for informed consent from human subjects specifically for the use of their samples for this research was waived by based on the new and revised Exemption categories (45CFR 46.104), meeting Exemption Category 4(ii): Information, which may include information about biospecimens, is recorded by the investigator in such a manner that the identity of the human subjects cannot readily be ascertained directly or through identifiers linked to the subjects, the investigator does not contact the subjects, and the investigator will not re-identify subjects. Institutional Review Board of MD Anderson Cancer Center approved the waiver of consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Disclosures related to this study: WFS, BVS, CH, CF and RL are co-inventors on patent WO2017189976A1 \u201cTargeted measure of transcriptional activity related to hormone receptors\u201d. WFS, CF and RL own shares of Delphi Diagnostics, without employment or administrative position. Disclosures unrelated to this study: WFS owns shares of IONIS Pharmaceuticals and has received honoraria from Merck during the past 12\u2009months. CH is currently an employee of Bristol-Myers Squibb. LP has received consulting fees and honoraria from Astra Zeneca, Merck, Novartis, Genentech, Eisai, Pieris, Immunomedics, Seattle Genetics, Almac, Biotheranostics and Syndax.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1189"}}